Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VAX-NK by VaxCell Biotherapeutics for Small-Cell Lung Cancer: Likelihood of Approval
VAX-NK is under clinical development by VaxCell Biotherapeutics and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData,...